Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemischer Name: (S)-N-(9-Fluorenylmethyloxycarbonyl)-L-2-aminooctadec-9-enoic acid // Synonyme: (S,Z)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)octadec-9-enoic acid, Fmoc-L-2-aminooctadec-9-enoic acid, Fmoc-L-2-amino-(9Z)-oleic acid, Fmoc-L-2-aminooctadec-9-enoic acid,Fmoc-2Aod-OH
Startet von auf Anfrage
Fatty amino acids improve the pharmacokinetic & pharmacologic properties of peptide APIs and other biopharmaceuticals. The most prominent block busters are Liraglutide and Semaglutide. Their lifetime in serum is drastically improved as the fatty acid residue helps to bind temporarily to serum albumin. This conjugation enhances stability towards proteolytic degradation and serves as drug delivery technique.
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide; J. Lau, P. Bloch, L. Schäffer, I. pettersson, J. Spetzler, J. Kofoed, K. Madsen, L. B. Knudsen, J. McGuire, D. B. Steensgaard, H. M. Strauss, D. X. Gram, S. M. Knudsen, F. S. Nielsen, P. Thygesen, S. Reedtz-Runge, T. Kruse; J. Med. Chem. 2015; 58(18): 7370-7378. https://doi.org/10.1021/acs.jmedchem.5b00726.
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues; E. M. Bech, M. C. Martos-Maldonado, P. Wismann, K. K. Sørensen, S. Blok van Witteloostuijm, M. B. Thygesen, N. Vrang, J. Jelsing, S. L. Pedersen, K. J. Jensen; J. Med. Chem. 2017; 60(17): 7434-7446. https://doi.org/10.1021/acs.jmedchem.7b00787.
Sie benötigen größere Mengen für Ihre Entwicklung oder Produktion?
Bitte senden Sie mir mehr Informationen über